MAPKs are involved in acetaminophen (APAP)-hepatotoxicity, but the regulatory mechanism remains unknown. Here, we explored the role of Spred-2 that negatively regulates Ras/ERK pathway in APAP-hepatotoxicity. Spred-2 knockout (KO) mice demonstrated exacerbated liver injury, an event that was associated with increased numbers of CD4 + T, CD8 + T and NK cells in the liver compared to the control. Levels of CXCL9/CXCL10 that attracts and activates these cells were enhanced in Spred-2 KO-liver. Kupffer cells isolated from Spred-2 KO mice after APAP challenge expressed higher levels of CXCL9/CXCL10 than those from the control. Upon stimulation with APAP and IFNγ, naïve Kupffer cells from Spred-2 KO mice expressed higher levels of CXCL9/CXCL10. NK cell-depletion attenuated APAP-hepatotoxicity with lowered hepatic IFNγ and decreased numbers of not only NK cells but also CD4 + T and CD8 + T cells in the liver. These results suggest that Spred-2 negatively regulates APAP-hepatotoxicity under the control of Kupffer cells and NK cells. Toxicology oxidative stress initiates APAP-hepatotoxicity [2], it is reasonable to speculate that MAPKs are involved in APAP-hepatotoxicity. In fact, mice injected with JNK inhibitor or lacking JNK (antisense treatment, siRNA, knock-out mice) were significantly protected against APAP-induced liver injury [6, 7], indicating a deleterious role of JNK-MAPK pathway. In contrast, p38-MAPK pathway does not appear to play a role [8].
Introduction
Acetaminophen (APAP) is widely used as a safety analgesic and antipyretic agent.
Although considered safe at therapeutic doses, an accidental or intentional APAP overdose often causes acute liver failure with high morbidity and mortality [1] . The hepatotoxicity is mediated by a toxic metabolite N-acetyl-p-benzoquinone imine (NAPQI). Normally, NAPQI is detoxified by glutathione in the liver. In overdose glutathione is exhausted, thereby NAPQI covalently binds to cellular proteins and nonprotein thiols, initiating hepatocellular death due to oxidative stress. Hepatocyte injury in turn induces expressions of inflammatory molecules including cytokines and chemokines, resulting in an extensive severe liver damage [2] .
There is a great interest in studying the cellular processes and signaling pathways during APAP-induced liver injury. We have found in a murine model of APAP-hepatotoxicity that suppressor of cytokine signaling (SOCS)3 in T cells negatively regulates hepato-damaging IFNγsignaling by inhibiting STAT1 activation [3] . IFNγ is also capable of activating MAPKs [4] , another principal signaling pathway that includes JNK-1/2, p38 and ERK-1/2. MAPKs are activated by various extracellular stimuli such as oxidative stress, mitogens, hormones, growth factors, cytokines and chemokines [5] . As inhibit Ras-dependent ERK signaling. Spred-2 is ubiquitously expressed in various tissues including liver whereas Spred-1 and Spred-3 are preferentially expressed in the brain and cerebellum [9, 10] . However, the physiological functions of Spred proteins in the liver pathology remain largely unknown. In the present study, we have focused on Spred-2 and investigated the role in the evolution of APAP-induced liver injury. We demonstrate that Spred-2 knockout (KO) mice show enhanced APAP-hepatotoxicity.
Our results suggest that the exacerbated liver injury in Spred-2 KO mice is due to the increased numbers of hepatotoxic lymphocytes such as CD4 + T cells, CD8 + T cells and NK cells, possibly by augmented CXCL9 and CXCL10 under the control of Kupffer cells and NK cells.
Materials and Methods

Mice
Spred-2 KO mice backcrossed into the C57BL/6J background have been previously reported [11, 12] . C57BL/6J mice were used as the wild-type (WT) mice. These mice were transferred to the Department of Animal Resources, Okayama University (Okayama, Japan) and then bred at the facility. Female mice (6-8 weeks) were used in this study under specific pathogen-free conditions. The mice were housed in a temperature-controlled environment with a 12-hour light/12-hour dark cycle and allowed free access to water and food. The animal care and use committee at Okayama University approved all experiments conducted in this study.
APAP-induced liver injury
Fresh suspensions of APAP (Sigma Chemical Co., St. Louis, MO) were made immediately before use by dissolving the compound in phosphate-buffered saline (PBS) warmed to 40°C [3] . Mice were fasted for 12 h with free access to water and then received intraperitoneal (i.p.) injection of APAP (400 mg/kg). At appropriate time intervals after APAP injection, mice were anesthetized, bled and sacrificed. Serum levels of alanine aminotransferase (ALT) were measured using standardized techniques.
The livers were perfused with saline, excised, snap frozen in liquid nitrogen, and stored at -80°C for subsequent analyses. A part of the liver was fixed in 10% formalin, embedded in paraffin, and the liver sections were stained with hematoxylin and eosin. For some experiments, NK cells and Kupffer cells were deleted prior to APAP challenge. For NK cell-deletion, reconstituted anti-asialo GM1 antiserum (ASGM1; 20 µl/mouse, Wako Pure Chemical Industries, Osaka, Japan) was i.p. injected 12 h prior to APAP challenge [13] . Normal rabbit serum was used as a control. To delete Kupffer cells, mice were i.v.
injected with 200 µl of clodronate encapsulated liposomes (Encapsula Nanosciences, Nashville, TN) 1 and 2 days before APAP-challenge. Empty liposomes were used as a control. All mice experiments were repeated two to three times and confirmed the reproducibility.
Detection of apoptosis and caspase activity
DNA fragmentation is a key feature of apoptosis. To detect DNA fragmentation in paraffin-embedded liver sections, ApopTag In Situ Detection Kit (Chemicon International, Inc., Temecula, CA) was used, according to manufacturers' instructions.
For the measurement of caspase-3, -8, -9 activities, colorimetric assay kit (MBL, Nagoya, Japan) for each caspase was used. The livers were homogenized in lysis buffer provided by the kit and the activities in the cytosolic extracts (100 µg protein) were measured with a kit. Protein concentrations in the extracts were measured by protein-dye binding assay (Bio-Rad Laboratories, Hercules, CA).
Reverse transcription-PCR (RT-PCR)
The tissues were homogenized in Trizol Reagent (Gibco BRL, Grand Island, NY), and total RNA was isolated. First-strand cDNA was constructed from 2 µg of total RNA with oligo (dT) [12] [13] [14] [15] [16] [17] [18] as primers, and the cDNAs were used as a template for PCR. Quantitative real-time PCR for Fas and FasL was performed with a StepOne with Power SYBR PCR master mix (Applied Biosystems, Foster City, CA). The primers were as follows: Fas, sense:
5'-CTGCGATGAAGAGCATGGTTT-3'; anti-sense:
5'-CCATAGGCGATTTCTGGGAC-3'. FasL, sense:
5'-AAGAAGGACCACAACACAAATCTG-3'; anti-sense:
5'-CCCTGTTAAATGGGCCACAC-3'. To validate the SYBR Green PCR products, a dissociation step was done to verify the T m (annealing temperature) of the SYBR Green PCR product after the PCR were run. The expression levels of each mRNA were normalized by the expression of a housekeeping gene β-actin (sense:
5'-GGTCATCACTATTGGCAACG-3'; anti-sense: 5'-ACGGATGTCAACGTCACACT-3').
mRNA expressions for IFNγ, CXCL9, CXCL10, CXCR3 and Spred-2 were measured by Taqman RT-PCR using GAPDH as the internal standard (Applied Biosystems). A standard Gel electrophoresis/RT-PCR was also carried out for Spred-2 and GAPDH.
The primers were as follows: Spred-2, sense:
5'-TGTGAGCACCGGAAGATTTATACC-3'; anti-sense:
5'-CGCGGCGGCTTTGTGCTT-3'. GAPDH, sense:
5'-TGTTCCAGTATGACTCCACTCACG-3'; anti-sense:
5'-TCTGGGTGGCAGTGATGGCATGGA-3'. The PCR was carried out at 95°C 3 min, 26 cycles of 95°C for 10 sec, 55°C for 10 sec, and 74°C for 1 min, and 74°C for 5 min.
Ten microliters of PCR products were subjected to electrophoresis on a 2% agarose gel in presence of ethidium bromide, photographed and digitized.
Isolation of hepatic leukocytes
Hepatic leukocytes were isolated from the fresh liver [14] . In brief, mice were anesthetized and the livers were perfused in situ via the portal vein with 60 ml of HBSS at a flow rate of 5 ml/min and then removed. The livers were minced and digested with 0.02% (w/v) collagenase and 0.0005% (w/v) DNase I in HBSS containing 20 mM HEPES, pH 7.4, at 37 °C for 30 min with occasional shaking. The resulting cell suspension was filtered through a 75-μm nylon mesh and the filtrate was washed once with HBSS, layered over a 1.037 g/ml solution of Percoll (GE healthcare Bio-Sciences, Uppsala, Sweden) and centrifuged at 400 × g for 20 min. The resulting upper layer and interface, containing Ito cells, dead cells, and debris, were removed. The lower layer was diluted with Dulbecco's PBS and centrifuged at 600 × g for 10 min to pellet the cells, re-suspended with PBS and the total cell numbers were counted by hemocytometer.
Flow cytometry
Hepatic leukocytes were suspended in PBS supplemented with 2% FCS and 0.1% sodium azaide, and stained with fluorescein isothiocyanate (FITC)-conjugated anti-CD3 
Splenocytes culture
Spleens were excised from WT and Spred-2 KO mice at 12 h after APAP treatment, and the splenocytes were dispersed into single-cell suspensions. After lysing red blood cells, the cells (5 × 10 6 cells/ml) were suspended in RPMI 1640 supplemented with 5% FCS, glutamine and antibiotics and cultured for 72 h without stimulation. The culture supernatants were used for measurement of cytokines.
Kupffer cell isolation and culture
Non-parenchymal cells were isolated as described above. CD11b + cells were isolated from the cells by anti-CD11b microbeads over MS + MiniMACS separation columns (Miltenyi Biotec, Bergisch-Gladbach, Germany) according to instructions supplied by the manufacturer. Most of the purified cells were alive (>97%, trypan blue exclusion) and routinely >95% CD11b + cells. The cells were plated onto 24 well at a density of 3 × 10 5 cells per well, incubated for 1 h, non-adherent cells were washed off with RPMI1640 and fresh medium containing 10% FBS, glutamine and antibiotics was added. The adherent Kupffer cells were then stimulated with APAP (10 µg/ml) and IFNγ (10 ng/ml) for 4 h.
RNA from each sample was purified using High Pure RNA Isolation Kit (Roche Diagnostics, Mannheim, Germany).
Western blotting
Cleared supernatants of liver homogenates were boiled with sample buffer that contained 1% SDS, 10 mmol/L Tris-HCl (pH 7.5), fractionated on SDS-polyacrylamide gel, and transferred to a nitrocellulose membrane. After blocking with TBS-T (Tris-buffered saline + 0.1% Tween-20) containing 5% skim milk for 1 h at room temperature, the membrane was incubated with antibodies to p44/42 MAPK (Erk1/2), phospho-p44/42 MAPK (Erk1/2), SAPK/JNK, phospho-SAPK/JNK, p38 MAPK, and phospho-p38 MAPK (Cell Signaling Inc, Beverly, MA) overnight at 4°C. After washing with TBS-T, the membrane was incubated with anti-HRP-linked antibody for 1 h at room temperature and visualized with an enhanced chemiluminescence system (Cell Signaling), photographed and digitized.
Measurement of cytokines
Murine cytokines were measured using a standard method of sandwich ELISA, as described [15, 16] . The captured antibodies, detection antibodies and the recombinant cytokines were purchased from R&D Systems (Minneapolis, MN). The ELISAs employed in this study did not cross-react with other murine cytokines available. For cytokine measurement in the liver, livers were homogenized in PBS containing 0.1%
TritonX-100 and complete protease inhibitor (Roche), centrifuged, and the cleared supernatants were obtained.
Statistics
Statistical significance was evaluated by ANOVA. A p < 0.05 was regarded as statistically significant. All data were expressed as mean ± SEM.
Results
Expression and role of Spred-2 in APAP-induced liver injury
To investigate the role of Spred-2, first experiments were conducted to examine the expression of endogenous Spred-2 in the liver. Consistent with previous reports [10, 17] , Spred-2 was constitutively expressed in the liver. The expression level was increased and peaked at 3 h after APAP challenge ( Fig. 1A ), suggesting that endogenous Spred-2 might be involved in APAP-induced liver injury.
To understand the contribution of Spred-2 in APAP-hepatotoxicity, we employed Spred-2 KO mice. No appreciable level of Spred-2 was detected in Spred-2 KO-liver ( Fig. 1A inset) . Taqman RT-PCR also showed no Spred-2 expression in Spred-2 KO-liver (data not shown). The data in Figure 1B demonstrated that ALT level, a specific marker of liver injury, was significantly increased in Spred-2 KO mice as compared to WT controls. Histologically, centrilobular liver necrosis was much severer in Spred-2 KO mice than that in the WT mice ( Fig. 1C and D) . There was no significant difference in basal level of ALT between the groups (WT vs. Spred-2 KO, 64.9 ± 7.4 vs.
65.7 ± 9.7 IU/L, not significant, 5 mice each). Basal glutathione levels in the liver were similar between the groups (WT vs. Spred-2 KO, 1.7 ± 0.1 vs. 1.9 ± 0.1 mM/g liver, not significant, 5 mice each). Thus, Spred-2 KO mice demonstrated exacerbated liver injury after APAP challenge.
Hepatocyte apoptosis in Spred-2 KO mice
In the mechanistic level, we first asked whether APAP-induced hepatocyte apoptosis would be augmented in Spred-2 KO mice. TUNEL staining of liver sections at 6 h post-APAP showed that apoptotic hepatocytes were increased in Spred-2 KO-liver, relative to the control ( Fig. 2A and B ). Caspases are a class of cysteine proteases involved in apoptosis. The data in Figure 2C demonstrated that activities of caspase-3, -8 and -9 in WT-liver were comparatively increased after APAP challenge, which were slightly augmented in Spred-2 KO-liver. Apoptosis is often initiated by death ligand/death receptor interactions, such as Fas ligand (FasL) with Fas, leading to a caspase activation cascade. mRNA expression of FasL, but not Fas, at 6 h post APAP was relatively increased in Spred-2 KO-liver compared to the controls (Fig. 2D ). Thus, the increases in caspases/FasL in Spred-2 KO-liver were modest, suggesting that these pathways were unlikely the main cause of augmented liver injury in Spred-2 KO mice.
Leukocyte populations in the liver after APAP challenge
Liver histology in APAP-induced liver injury in humans shows hepatocyte damage with lymphocytic accumulation [18] . Experiments were conducted to examine the leukocyte populations in the liver. As shown in Figure 3A , the numbers of total leukocytes in the liver were increased with time in WT mice, which was significantly augmented in Spred-2 KO mice. FACS analyses at 6 h post APAP challenge revealed that hepatotoxic lymphocytes that include CD4 + T cells, CD8 + T cells and NK cells (CD3 -NK1.1 + ) were significantly increased in Spred-2 KO-liver as compared to the control (Fig. 3B) 
Increased IFNγ, CXCL9 and CXCL10 in Spred-2 KO mice
APAP overdose results in elevated cytokines in the circulation. IFNγ is crucial in APAP-hepatotoxicity [19, 20] , which stimulates the production of IFNγ-inducible chemokine CXCL9/CXCL10 that attracts and activates hepatotoxic lymphocytes such as CD4 + T cells, CD8 + T cells and NK cells [21] . We therefore investigated the cytokine response after APAP challenge. The data in Figure 4A showed that circulating levels of IFNγ, CXCL9 and CXCL10 were elevated in Spred-2 KO mice in comparison to those in WT mice. Hepatic levels of CXCL9, CXCL10 and their receptor CXCR3 were increased in Spred-2 KO mice (Fig. 4B ). Basal levels of these cytokine/chemokines 
Cells responsible for enhanced IFNγ, CXCL9 and CXCL10 in Spred-2 KO mice
Splenocytes harvested from either APAP-treated WT or Spred-2 KO mice did not spontaneously release appreciable levels of IFNγ, CXCL9 and CXCL10 (data not shown),
suggesting that these cytokine/chemokines were produced not from circulating cells rather from cells in the liver. Kupffer cells are resident macrophage population in the liver with a potent capacity to produce multiple cytokines/chemokines [22] , suggesting a possible source of hepatotoxic cytokine/chemokines in this model. To address this, Kupffer cells were isolated from WT and Spred-2 KO mice after APAP challenge and the expressions of these cytokine/chemokines were measured. As shown in Figure 5A , expressions of CXCL9 and CXCL10 in Kupffer cells were significantly elevated in Spred-2 KO mice as compared to those in WT mice. IFNγ was not detected in Kupffer cells from WT and Spred-2 KO mice (not shown). Accordingly, Kupffer cells were isolated from non-treated WT and Spred-2 KO mice and stimulated with APAP in vitro, which demonstrated that Kupffer cells from Spred-2 KO mice expressed significantly higher levels of CXCL9 and CXCL10 than those from the WT mice ( Fig. 5B ). No IFNγ was detected from WT-and Spred-2 KO-Kupffer cells (data not shown). Upon stimulation with IFNγ, naïve Kupffer cells from Spred-2 KO mice also expressed higher levels of CXCL9 and CXCL10 in comparison to the controls (Fig. 5C ) with no endogenous IFNγ (data not shown). The results suggest that Kupffer cells could be the source of the augmented CXCL9 and CXCL10 in Spred-2 KO mice. Together with data in Figure 4C , IFNγ appears to be derived from hepatotoxic lymphocytes.
NK cells affect the augmented hepatotoxic T cell response in Spred-2 KO mice
NK cells are known play a central role in APAP-hepatotoxicity by producing IFNγ [20] .
To understand the role of NK cells in this model, we attempted to delete NK cells by anti-ASGM1 in Spred-2 KO mice. The data in Figure 6A showed that anti-ASGM1 treatment significantly decreased IFNγ expression in the liver. Under the conditions, ALT level was decreased for up to 50% after the treatment with anti-ASGM1 ( Fig. 6B ).
Histologically, centrilobular liver necrosis induced by APAP was dramatically improved by anti-ASGM1 as compared to the control (Fig. 6C ). FACS analyses revealed that expression of perforin and granzyme B, injurious molecules produced from NK cells and CD8 + T cells, was reduced in Spred-2 KO-liver ( Fig. 6D ).
Leukocyte populations after anti-ASGM1 treatment were next examined.
Anti-ASGM1 treatment resulted in an 87% reduction in the number of NK cells in the liver (Table 1) . Subsequently, other leukocyte populations were also examined in the liver. Hepatic number of NKT cells was not affected by anti-ASGM1. Very interestingly, the numbers of CD4 + T cells and CD8 + T cells in the liver were considerably decreased after anti-ASGM1 treatment. Conversely, there was a trend toward increase in the number of CD4 + FoxP3 + T cells (p=0.14). The number of macrophages (CD11b + F4/80 + cells) was unchanged while that of neutrophils (CD11b + Ly6G + cells) was decreased by 50% although it was not statistically significant (Table 1) . IFNγ positive cells in CD8 + T and NKT cells, but not CD4 + T cell were decreased in mice treated with anti-ASGM1 ( Fig.   6E ). Thus, depletion of NK cells attenuated APAP-hepatotoxicity in Spred-2 KO mice, an event that was associated with decreased numbers of CD4 + T and CD8 + T cells and decreased IFNγ positive cells in CD8 + T cells and NKT cells. NK cells appear to be crucial in the subsequent recruitment of leukocytes and production of IFNγ from specific cell populations.
Discussion
Molecular interactions between toxicants and biological pathways are an emerging field of toxicology. Ras is a key-signaling molecule, and Spred proteins have a negative impact on
Ras/Raf/ERK pathway by binding to Ras and consequently inhibiting phosphorylation of
Raf [17] . In the present study, we have focused on Spred-2 in liver immunology and demonstrated for the first time that Spred-2 is protective in APAP-induced hepatotoxicity, as deletion of Spred-2 was vulnerable to the injury.
The exaggerated liver injury in Spred-2 KO mice appeared to be ascribed to the augmented numbers of hepatotoxic lymphocytes such as CD4 + T cells, CD8 + T cells and NK cells. IFNγ is crucial in the immune response during APAP-hepatotoxicity [19, 20] .
Both CD4 + cells and CD8 + T cells, known as type I effector T cells, are major sources of
IFNγ. NK cells are deleterious in APAP-hepatotoxicity by producing IFNγ [20] . In this study, we showed that IFNγ-positive CD4 + T cells, CD8 + T cells and NK cells were increased in the liver from Spred-2 KO mice. In addition, IFNγ-inducible CXCL9/CXCL10 that attracts and activates these cell types was significantly augmented in the liver form Spred-2 KO mice. Increased CXCL9 and CXCL10 in Spred-2 KO mice appeared to result from the activation of Ras and p38. Activation of Ras promoted the overexpression of CXCL10 in human breast cancer cells primarily through the Raf and PI3K signaling pathways [23] . p38 participated in the regulation of CXCL9/CXCL10
expression [4] . The numbers of NKT cells; also known to be deleterious in APAP-hepatotoxicity were unchanged in our model, although the cells can be attracted by CXCL9 and CXCL10. This may be a result of activation-induced cell death or loss of surface marker expression of NKT cells [24, 25] .
Very interestingly, reduction of NK cells with anti-ASGM1 significantly decreased APAP-induced liver injury with reduction in the hepatic numbers of not only NK cells but also CD4 + T cells and CD8 + T cells. Liver lymphocytes are abundant in NK cells (5-10%) and play an important role in first-line innate defense in the liver. NK cells directly and indirectly kill target cells by enhancing immune response through IFNγ production [26] . Decreased CD4 + T cells and CD8 + T cells by anti-ASGM1 may be its direct effect on these cells. It has demonstrated that ASGM1 is also expressed on certain CD4 + T cells [27] and CD8 + T cells [28] . Alternatively, NK cell deletion by anti-ASGM1 may affect regulatory T cell differentiation. Activated NK cells interfere with CD28-mediated Foxp3 expression in CD4 + CD25 -T cells [29] . NK cells lyse CD4 + CD25 + Foxp3 + T cells in certain conditions [30] . In the present study, NK cell depletion led to a trend toward increase in the number of regulatory T cells. The mechanism underlying the effects of anti-ASGM1 deserves attention. Employing anti-NK1.1 antibody or NKT-KO mice (CD1dKO mice) could be helpful to further understand the mechanism(s).
A previous study suggested that NK and NKT cells were not involved in APAP-hepatotoxicity [31] . Unlike in case of dimethylsulfoxide (DMSO) as a solvent, APAP failed to activate and recruit hepatic NK and NKT cells when dissolved in saline, suggesting that DMSO may play a role. However, in the present study, we clearly showed that APAP dissolved in PBS actually activated hepatic NK cells but not NKT cells as evidenced by increased NK cell numbers and higher intracellular levels of IFNγ, which was augmented in Spred-2 KO mice. We believe that NK cells play a role in APAP-hepatotoxicity under physiological conditions. Kupffer cells are located within the lumen of the liver sinusoids, and are the first cell population encounters various stimuli including toxins, and release reactive oxygen species (ROS), cytokines and chemokines upon stimulation [22] . Our results suggest that Kupffer cells are responsible for the augmented CXCL9 and CXCL10 response in Spred-2 KO mice. NK cells together with Kupffer cells are preferentially located in the hepatic sinusoids, often adhering to the endothelial cells [32] . NK cells may assist Kupffer cells to induce CXCL9 and CXC10 by releasing IFNγ.
A question arises whether deletion of Kupffer cells could dampen the augmented liver injury in Spred-2 KO mice. The functional role of Kupffer cells in APAP-hepatotoxicity remains controversial. Previous studies showed that APAP-hepatotoxicity could be dramatically reduced by several Kupffer cell inactivators [33] ; however, others showed an exacerbated APAP-liver injury in the absence of Kupffer cells [34, 35] . After Kupffer cell deletion with liposome/clodronate, we failed to reduce the augmented APAP-hepatotoxicity in Spred-2 KO mice. Serum ALT level was rather increased (liposome/control vs. liposome/clodronate, 5,152 ± 2,461 IU/L vs. Recently, it has demonstrated that M2 macrophages that generate IL-10 are recruited into the liver after APAP challenge [36] . Mice deficient in CC chemokine receptor 2 (CCR2), the receptor for CCL2, showed reduced M2 accumulation during APAP hepatotoxicity and consequently a substantial delay in tissue repair with increased neutrophil infiltration [36, 37] . These data suggest that liposome/clodronate also deletes M2 macrophage from the body, resulting in an enhanced APAP-induced liver injury via decreased IL-10. Thus, the controversy may stem from the heterogeneity and/or plasticity of macrophages and the difficulty in distinguishing and differentially studying subpopulations of macrophages in the liver.
The other point needs to address in this study is the role of Spred-2 in parenchymal hepatocytes. Lacking Spred-2 in hepatocytes may directly affect APAP-hepatotoxicity. Hepatocytes are known to produce CXCL9 and CXCL10 [38] .
However, using primary hepatocytes from WT and Spred-2 KO-liver, we did not find Table 1 The numbers of leukocyte populations in the liver after ASGM1 treatment cell types control ( × 10 5 cells) ASGM1 ( × 10 5 cells)
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